Piramal Enterprises Profile
Key Indicators
- Authorised Capital ₹ 5,155.00 Cr
- Paid Up Capital ₹ 45.10 Cr
- Company Age 77 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24,864.10 Cr
- Satisfied Charges ₹ 32,053.79 Cr
- Revenue Growth 79.61%
- Profit Growth 2404.59%
- Ebitda 1454.48%
- Net Worth 3.95%
- Total Assets 10.79%
About Piramal Enterprises
Piramal Enterprises Limited (PEL) was founded in India on 26 April 1947 and has a glorious history of 77 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500302 and on the National Stock Exchange(NSE) under PEL.
The Corporate was formerly known as Nicholas Piramal (India) Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5,155.00 Cr and a paid-up capital of Rs 45.10 Cr.
The company currently has active open charges totaling ₹24,864.10 Cr. The company has closed loans amounting to ₹32,053.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Piramal Enterprises Limited India are Upma Goel as CFO and Bipin Singh as Company Secretary. Kunal Bahl, Suhail Nathani, Anita George, and Ten other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
What products or services does Piramal Enterprises Limited offer?
Piramal Enterprises Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Pharma Ingredients & Raw Materials, Vitamin Powder API, Third Party Manufacturing Consultancy, Pharmaceutical Contract Manufacturing Services, Medical Test Services, Diagnostic Imaging Services, Investment Advisory Services, Capital Market Advisory.
Who are the key members and board of directors at Piramal Enterprises?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Upma Goel  | CFO | 18-Aug-2022 | Current |
| Bipin Singh | Company Secretary | 30-Jul-2019 | Current |
Board Members (13)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Shah | Director | 01-Jan-2012 | Current |
Suhail Nathani  | Director | 14-Oct-2020 | Current |
| Shikha Sharma | Director | 31-Mar-2022 | Current |
| Puneet Dalmia | Director | 07-Oct-2021 | Current |
| Anjali Bansal | Director | 19-Nov-2020 | Current |
| Ajay Piramal | Whole-Time Director | 07-Mar-1988 | Current |
Financial Performance of Piramal Enterprises.
Piramal Enterprises Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 79.61% increase. The company also saw a substantial improvement in profitability, with a 2404.59% increase in profit. The company's net worth moved up by a moderate rise of 3.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Piramal Enterprises?
In 2022, Piramal Enterprises had a promoter holding of 43.49% and a public holding of 56.50%. The company had 19 Subsidiaries and 7 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
The Indo-Canadian Business ChamberAnita George is a mutual person
Sun Pharma Laboratories LimitedGautam Doshi is a mutual person
Sun Pharmaceutical Industries LimitedGautam Doshi is a mutual person
Salaam Bombay FoundationSuhail Nathani is a mutual person
Piramal Glass Private LimitedSwati Piramal and Ajay Piramal are mutual person
Nestle India LimitedAnjali Bansal is a mutual person
Charges (Loans)
₹24,864.10 Cr
₹32,053.79 Cr
Charges Breakdown by Lending Institutions
- Idbi Trusteeship Services Limited : 17715.00 Cr
- Others : 5493.65 Cr
- Standard Chartered Bank : 1650.00 Cr
- Unit Trust Of India : 3.00 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 1.60 Cr
- Others : 0.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Mar 2024 | Idbi Trusteeship Services Limited | ₹50.00 Cr | Open |
| 26 Feb 2024 | Others | ₹750.00 Cr | Open |
| 03 Jan 2024 | Idbi Trusteeship Services Limited | ₹150.00 Cr | Open |
| 29 Dec 2023 | Idbi Trusteeship Services Limited | ₹250.00 Cr | Open |
| 29 Nov 2023 | Others | ₹250.00 Cr | Open |
How Many Employees Work at Piramal Enterprises?
Piramal Enterprises has a workforce of 241 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Piramal Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Piramal Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
